Related Experiment Videos
[Anticentromere antibodies. Diagnostic and prognostic value]
La Nouvelle Presse Medicale
|October 9, 1982
Summary
Anticentromere antibodies were detected in patients with scleroderma and other connective diseases. These antibodies strongly correlate with benign scleroderma forms like CREST syndrome.
Area of Science:
- Immunology
- Rheumatology
- Cell Biology
Context:
- Scleroderma and other connective tissue diseases involve complex autoimmune responses.
- Identifying specific autoantibodies aids in disease classification and understanding pathogenesis.
Purpose:
- To investigate the prevalence and significance of antinuclear antibodies, specifically anticentromere antibodies (ACA).
- To correlate the presence of ACA with clinical manifestations in patients with scleroderma and related conditions.
Summary:
- An indirect immunofluorescence assay on Hep-2 cells was employed to detect antinuclear antibodies.
- Anticentromere antibodies were identified in 25 patients, including those with diffuse scleroderma, Raynaud's disease, rheumatoid arthritis, lupus, and dermatomyositis.
- A significant association was observed between ACA and milder forms of scleroderma, particularly the CREST syndrome.
Impact:
- The findings highlight ACA as a valuable serological marker for identifying benign scleroderma subtypes.
- This aids in differential diagnosis and potentially guides patient management strategies.
- Contributes to the understanding of autoimmune targets in connective tissue diseases.